FindTrial
Sign In

Adherence study of oral chemotherapy drugs in patients with gastrointestinal tumors

Adherence study of oral chemotherapy drugs in patients with gastrointestinal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075731
Enrollment
Unknown
Registered
2023-09-14
Start date
2022-06-30
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric and colorectal cancer

Interventions

Gastric cancer group/ Colorectal cancer group:None

Sponsors

The First Affiliated Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Patients with pathological diagnosis of gastric and colorectal cancer; 2: Oral treatment with Capecitabine or Tigio; 3: At least 18 years old.

Exclusion criteria

Exclusion criteria: 1: Individuals with severe psychological disorders, cognitive impairments, and mental illnesses; 2: Patients with incomplete medical records 3: Individuals with severe systemic infections, severe anemia, cachexia, and severe organ dysfunction.

Design outcomes

Primary

MeasureTime frame
High medication adherence or low medication adherence;—

Countries

China

Contacts

Public ContactHongBin Xu

The First Affiliated Hospital of Ningbo University

jiang_rh@126.com+86 189 5178 3095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026